{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:23:39Z","timestamp":1780727019586,"version":"3.54.1"},"reference-count":18,"publisher":"Scientific Scholar","issue":"03","license":[{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Lab Physicians"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Background\u2003Endometrial carcinoma is often preceded by characteristic histopathologic lesions known as endometrial hyperplasia. Estrogen, p53, PTEN, and overexpression of cyclin D1 appear to be involved in the development of endometrial carcinogenesis.<\/jats:p><jats:p>Design\u2003We evaluated and compared the expression profile of cyclin D1 expressions in 50 endometrial samples submitted as either endometrial curetting (n = 34) or hysterectomy (n = 16) specimens, which were diagnosed as simple hyperplasia (n = 10), complex hyperplasia (n = 06), atypical hyperplasia (n = 04), and endometrial carcinoma (n = 20). Ten cases of normal proliferative and secretory endometrium were selected as controls. Breast cancer with known cyclin D1 expression was selected as a positive control in each immunohistochemistry run.<\/jats:p><jats:p>Results\u2003Cyclin D1 was significantly overexpressed in glands with complex hyperplasia and endometrial adenocarcinoma compared with proliferative or secretory endometrium and simple hyperplasia. A statistical difference was found in the extent of cyclin D1 positivity of simple hyperplasia and carcinoma of the endometrium (p &lt; 0.005). No statistical difference was seen between complex hyperplasia and carcinoma and clinicopathologic parameters in endometrioid carcinomas. All cases of clear cell carcinoma and serous carcinoma showed cyclin D1 immunoreactivity. Significant statistical difference was seen between cyclin D1 expression and only one clinicopathologic parameter, i.e., menopausal status in endometrial carcinomas<\/jats:p><jats:p>Conclusion\u2003Cyclin D1 over expression may be an early event in endometrial carcinogenesis and cyclin D1 over expression may be an informative biomarker to recognize subsets of endometrial lesions that may be precancerous and therefore amenable to surgical therapy.<\/jats:p>","DOI":"10.1055\/s-0040-1721150","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T13:27:49Z","timestamp":1606224469000},"page":"165-170","source":"Crossref","is-referenced-by-count":7,"title":["Expression of Cyclin D1 in Hyperplasia and Carcinoma of Endometrium and Its Correlation with Histologic Grade, Tumor Type, and Clinicopathological Features"],"prefix":"10.25259","volume":"12","author":[{"given":"Karuna","family":"Sangwan","sequence":"additional","affiliation":[{"name":"Department of Pathology, World College of Medical Science and Research, Jhajjar, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Pathology, Government Medical College, Patiala, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayana","family":"Pathak","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, MM Institute of Medical Sciences & Research, Mullana, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavleen","family":"Bharti","sequence":"additional","affiliation":[{"name":"Department of Pathology, Government Medical College, Patiala, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"key":"ref1","first-page":"290","volume-title":"Tumors of the uterine corpus and gestational trophoblastic disease","author":"S G Silverberg","year":"1992"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1746-1596-8-8","article-title":"An analysis of cyclin D1, cytokeratin 5\/6 and cytokeratin 8\/18 expression in breast papillomas and papillary carcinomas","volume":"8","author":"Y Wang","year":"2013","journal-title":"Diagn Pathol"},{"issue":"04","key":"ref3","first-page":"277","article-title":"Immunoexpression of cyclin D1 and PTEN in various endometrial pathologies","volume":"26","author":"S Shawana","year":"2016","journal-title":"J Coll Physicians Surg Pak"},{"issue":"04","key":"ref4","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/j.1525-1438.2006.00642.x","article-title":"Correlation of cyclin D1 and cyclin D3 overexpression with the loss of PTEN expression in endometrial carcinoma","volume":"16","author":"W Wu","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/IGC.0b013e31820cc305","article-title":"The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered?","volume":"21","author":"N R Abu-Rustum","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"03","key":"ref6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.gde.2010.03.001","article-title":"The inherited genetics of ovarian and endometrial cancer","volume":"20","author":"S A Gayther","year":"2010","journal-title":"Curr Opin Genet Dev"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"J V Bokhman","year":"1983","journal-title":"Gynecol Oncol"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/1477-3163.100401","article-title":"Cyclin D1 protein plays different roles in modulating chemoresponses in MCF7 and MDA-MB231 cells","volume":"11","author":"Y Sun","year":"2012","journal-title":"J Carcinog"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: positive and negative regulators of G1-phase progression","volume":"13","author":"C J Sherr","year":"1999","journal-title":"Genes Dev"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.5858\/2002-126-0459-EOCDIN","article-title":"Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis","volume":"126","author":"M Ruhul Quddus","year":"2002","journal-title":"Arch Pathol Lab Med"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00404-003-0595-5","article-title":"Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables","volume":"271","author":"S \u00d6zuysal","year":"2005","journal-title":"Arch Gynecol Obstet"},{"issue":"04","key":"ref12","first-page":"708","article-title":"Expression of cyclin D1 in endometrial hyperplasia and endometrial carcinoma","volume":"50","author":"M Choudhury","year":"2007","journal-title":"Indian J Pathol Microbiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1746-1596-8-138","article-title":"Cyclin D1, a prominent prognostic marker for endometrial diseases","volume":"8","author":"S Liang","year":"2013","journal-title":"Diagn Pathol"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/modpathol.2009.33","article-title":"Expression of cell cycle regulatory proteins in endometrial adenocarcinoma: variations in conventional tumor areas and in microcystic, elongated and fragmented glands","volume":"22","author":"C JR Stewart","year":"2009","journal-title":"Mod Pathol"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/0022-3859.147025","article-title":"Cyclin D1 and Ki-67 expression in normal, hyperplastic and neoplastic endometrium","volume":"61","author":"C R Shevra","year":"2015","journal-title":"J Postgrad Med"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/gyn.2012.0145","article-title":"Cyclin D1 expression in hyperplasia and carcinoma of the endometrium and its correlation with histologic grade and tumor type","volume":"30","author":"M Kala","year":"2014","journal-title":"J Gynecol Surg"},{"issue":"04","key":"ref17","first-page":"2185","article-title":"Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis","volume":"24","author":"Y Nishimura","year":"2004","journal-title":"Anticancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.anndiagpath.2017.04.006","article-title":"Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients","volume":"30","author":"M N Khabaz","year":"2017","journal-title":"Ann Diagn Pathol"}],"container-title":["Journal of Laboratory Physicians"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0040-1721150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T08:16:48Z","timestamp":1703405808000},"score":1,"resource":{"primary":{"URL":"https:\/\/jlabphy.org\/expression-of-cyclin-d1-in-hyperplasia-and-carcinoma-of-endometrium-and-its-correlation-with-histologic-grade-tumor-type-and-clinicopathological-features\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":18,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2020,11,23]]},"published-print":{"date-parts":[[2020,12]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0040-1721150","relation":{},"ISSN":["0974-2727","0974-7826"],"issn-type":[{"value":"0974-2727","type":"print"},{"value":"0974-7826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,23]]}}}